Strict glycemic control and symptom-directed therapies are key to managing diabetic autonomic neuropathy.
Prioritizes glycemic control in diabetic autonomic neuropathy management; leaves open optimal targets and durability of reversal.
Diabetic autonomic neuropathy can cause heart disease, gastrointestinal symptoms, genitourinary disorders, and metabolic disease. Strict glycemic control can slow the onset of diabetic autonomic neuropathy and sometimes reverse it. Pharmacologic and nonpharmacologic therapies are available to treat symptoms.
No takes yet. Share an insight, caveat, or question.
Vinik et al. (2001) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: